CIK 0001635088
- Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- Operating
- EIN
- 981173944
- Phone
- +44 12955950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Shares withheld for taxes Director gave up 293 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 54 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 123 shares (to pay taxes)
- 4 Grant or award Chief Accounting Officer acquired 38,685 shares (grant or award)
- 4 Grant or award CFO acquired 38,685 shares (grant or award)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 8,515 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 9,881 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 16,002 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
- 4 Shares withheld for taxes Pres&Chief Investment Officer gave up 366,211 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 215,991 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 16,003 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,506 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Other disposition Director disposed of 30,257,723 shares (other)
- 4 Other disposition Director disposed of 45,821,757 shares (other)
- 4 Other disposition 10% owner disposed of 45,821,757 shares (other)
- 4 Shares withheld for taxes CFO gave up 1,630 shares (to pay taxes)
Page 13 of 26 · 511 filings